Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Atos Group strengthens its management team to further execute and accelerate its transformation plan (GlobeNewswire EN) +++ ATOS Aktie +3,11%

OXFORD NANOPORE Aktie

 >OXFORD NANOPORE Aktienkurs 
2.16 EUR    +1.9%    (Tradegate)
Ask: 2.155 EUR / 2400 Stück
Bid: 2.115 EUR / 2500 Stück
Tagesumsatz: 30121 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>OXFORD NANOPORE Performance
1 Woche: -13,0%
1 Monat: -12,1%
3 Monate: +41,5%
6 Monate: +55,6%
1 Jahr: +47,3%
laufendes Jahr: +38,3%
>OXFORD NANOPORE Aktie
Name:  OXFORD NANOPORE TECHNOLOGIES
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GB00BP6S8Z30 / A3C307
Symbol/ Ticker:  4R0 (Frankfurt)
Kürzel:  FRA:4R0, ETR:4R0, 4R0:GR
Index:  -
Webseite:  https://nanoporetech.com/
Profil:  Oxford Nanopore Technologies Ltd. is a transformat..
>Volltext..
Marktkapitalisierung:  2012.1 Mio. EUR
Unternehmenswert:  1658.98 Mio. EUR
Umsatz:  196.14 Mio. EUR
EBITDA:  -116.76 Mio. EUR
Nettogewinn:  -156.52 Mio. EUR
Gewinn je Aktie:  -0.17 EUR
Schulden:  49.21 Mio. EUR
Liquide Mittel:  213.62 Mio. EUR
Operativer Cashflow:  -107.47 Mio. EUR
Bargeldquote:  3.03
Umsatzwachstum:  13.14%
Gewinnwachstum:  0.86%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  OXFORD NANOPORE
Letzte Datenerhebung:  01.09.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 962.19 Mio. St.
Frei handelbar: 32.69%
Rückkaufquote: -4.31%
Mitarbeiter: 1480
Umsatz/Mitarb.: 0.13 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 8.82%
Bewertung:
KGV: -
KGV lG: -
KUV: 9.53
KBV: 2.86
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 57.53%
Gewinnmarge: -79.8%
Operative Marge: -83.16%
Managementeffizenz:
Gesamtkaprendite: -18.93%
Eigenkaprendite: -23.77%
>Peer Group

Es sind 81 Aktien bekannt.
 
30.08.25 - 10:24
Oxford Nanopore heads for interim results with investors wanting more detail on growth prospects (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
29.08.25 - 13:24
Oxford Nanopore heads for interim results with investors wanting more detail on growth prospects (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
11.08.25 - 17:24
Gordon Sanghera to step down as Oxford Nanopore CEO (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
11.08.25 - 12:18
IN BRIEF: Oxford Nanopore Technologies CEO to leave at end of 2026 (Alliance)
 
Oxford Nanopore Technologies PLC - Oxford, England-based specialist in DNA and RNA sequencing technologies - Chief Executive...
07.08.25 - 09:12
Oxford Nanopore suing MGI Australia over alleged patent infringements (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 17:00
Up 20%! Here’s why Oxford Nanopore stock topped the FTSE 250 today (Fool)
 
This under-the-radar growth stock in the FTSE 250 index just jumped to a 52-week high. Can it keep climbing higher from here? The post Up 20%! Here's why Oxford Nanopore stock topped the FTSE 250 today appeared first on The Motley Fool UK....
21.07.25 - 16:48
Oxford Nanopore leaps 20% after stronger first half trading (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 11:06
Oxford Nanopore shares climb after revenue rises 25% in first half (Alliance)
 
Oxford Nanopore Technologies PLC on Monday left its full-year outlook unchanged, though revenue was higher-than-expected in the first half of 2025.The Oxford,England-based biomedical company focuses......
21.07.25 - 10:18
Early market roundup: European stocks mixed but FTSE 100 above 9,000 (Alliance)
 
Stocks in Europe moved little on Monday morning but mining stocks enjoyed a boost, while Oxford Nanopore Technologies on the FTSE 250 rose as it......
12.06.25 - 18:03
Volta Labs Expands Long-Read Sequencing Capabilities with Automated Oxford Nanopore Library Prep App on Callisto™ (PR Newswire)
 
BOSTON, June 12, 2025 /PRNewswire/ -- Volta Labs, a genomics applications company, today announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample Prep System. This latest addition to the growing Volta apps menu extends Callisto's footprint in......
20.05.25 - 11:06
LONDON BROKER RATINGS: Kingfisher cut; Peel Hunt ups Oxford Nanopore (Alliance)
 
The following London-listed shares received analyst recommendations Tuesday morning and on Monday:----------FTSE 100----------Barclays cuts Kingfisher to 'underweight' (equal weight) - price target 280 (275) pence----------Deutsche......
06.05.25 - 10:54
LONDON BROKER RATINGS: Investec starts Oxford Nanopore with ′buy′ (Alliance)
 
The following London-listed shares received analyst recommendations Tuesday morning, Monday and on Friday:----------FTSE 100----------RBC cuts London Stock Exchange price target to 13,400 (14,000) pence -......
09.04.25 - 14:54
Oxford Nanopore teams up with Danaher subsidiary Cepheid (Alliance)
 
Oxford Nanopore Technologies PLC on Wednesday announced a collaboration aimed at advancing automated sequencing-based solutions.The Oxford-based specialist in DNA and RNA sequencing technologies said it......
09.04.25 - 13:01
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions (PR Newswire)
 
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., April 9, 2025 /PRNewswire/ -- Oxford Nanopore Technologies, the company behind a new......
04.03.25 - 16:48
Gene-Sequencing Firm Oxford Nanopore Hit by US, China Turmoil (Bloomberg)
 
Gene-sequencing company Oxford Nanopore Technologies Plc's shares plunged the most in more than a year as uncertainty around cuts to US research funding and the impact of a global trade war eclipsed the firm's plans to forge ties with the pharmaceutical industry....
04.03.25 - 14:30
TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain? (Zacks)
 
Bio-Techne's Asuragen brand inks a partnership with Oxford Nanopore Technologies to launch research-use-only AmplideX Nanopore Carrier Plus Kit....
04.03.25 - 12:12
Oxford Nanopore closer to profitability after revenue growth in 2024 (Alliance)
 
Oxford Nanopore Technologies PLC on Tuesday reaffirmed its financial targets, projecting adjusted earnings before interest, tax, depreciation, and amortisation breakeven by 2027 and cash flow......
03.03.25 - 13:01
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes (PR Newswire)
 
AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England, March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore......
14.01.25 - 11:36
Here’s why Oxford Nanopore Technologies stock is up 15% in the FTSE 250 (Fool)
 
This innovative FTSE 250 stock has had a solid start to the year, rising 15% in just two days. Is it time I considered adding it to my portfolio? The post Here's why Oxford Nanopore Technologies stock is up 15% in the FTSE 250 appeared first on The Motley Fool UK....
13.01.25 - 10:36
Oxford Nanopore buoyed by improved margins and strong sales growth (Alliance)
 
Oxford Nanopore Technologies PLC on Monday said it is on-track for financial breakeven in 2027, as it expects to report better-than-expected margins in 2024 alongside......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Fast jeder Beruf ist mehr als Beruf: Eine leichte Krankheit, ja Verrücktheit der Seele. - Charles Tschopp
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!